Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[EGFR and KRAS Gene Mutations in 754 Patients with Resectable Stage I-IIIa Non-small Cell Lung Cancer and Its Clinical Significance].

Zhongguo fei ai za zhi = Chinese journal of lung cancer - 20 Sept 2017

Zhao Jing, Gao Jie, Guo Liping, Hu Xiaoxu, Liu Qi, Zhao Jinyin, Liu Licheng, Jiang Jun, Wang Mengzhao, Liang Zhiyong, Xu Yan, Chen Minjiang, Zhang Li, Li Longyun, Zhong Wei

Abstract excerpt

BACKGROUND: Epidermal growth factor receptor (EGFR) and KRAS gene are important driver genes of non-small cell lung cancer (NSCLC). The studies are mainly focused on detection of EGFR gene for advanced NSCLC, and the mutation feature of EGFR and KRAS gene in early NSCLC tissue is unknown. This study aims to investigate the mutations of EGFR and KRAS gene in NSCLC, and the relationship between the genotype and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Aged

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Aged, 80 and over

Share to Carcinoma, Non-Small-Cell Lung

Share to ErbB Receptors

Share to Lung Neoplasms

Share to Proto-Oncogene Proteins p21(ras)

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 28935015
DOI: 10.3779/j.issn.1009-3419.2017.09.05
PMCID: PMC5973370

Genes

EGFR
KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[EGFR and KRAS Gene Mutations in 754 Patients with Resectable Stage I-IIIa Non-small Cell Lung Cancer and Its Clinical Significance].PMID 28935015Read ↗

[Research Progress of KRAS Mutation in Non-small Cell Lung Cancer].Semantic proximity Read ↗

[Detection and Analysis of EGFR and KRAS Mutation with Lung Adenocarcinoma].Semantic proximity Read ↗

[Clinical Analysis of 107 NSCLC Patients Harboring KRAS Mutation].Semantic proximity Read ↗

KRAS mutations in advanced non-small cell lung cancer: From biology to novel therapeutic strategies.Semantic proximity Read ↗

[A Case Report of Advanced Lung Adenocarcinoma Harboring KRAS Mutation Treated with Anlotinib].Semantic proximity Read ↗

[Predictive role of EGFR mutation status on postoperative prognosis in patients with resected lung adenocarcinomas].Semantic proximity Read ↗

EGFR mutations in early-stage and advanced-stage lung adenocarcinoma: Analysis based on large-scale data from China.Semantic proximity Read ↗

[Relationship between EGFR and KRAS mutations and prognosis in Chinese patients with non-small cell lung cancer: a mutation analysis with real-time polymerase chain reaction using scorpion amplification refractory mutation system].Semantic proximity Read ↗

[Mutation status of epidermal growth factor receptor and KRAS gene in non-small cell lung cancers at Xuanwei regions of Yunnan Province].Semantic proximity Read ↗

The prevalence and prognostic significance of KRAS mutation subtypes in lung adenocarcinomas from Chinese populationsSemantic proximity Read ↗

EGFR and KRAS mutations in Turkish non-small cell lung cancer patients: a pilot study.Semantic proximity Read ↗

EGFR mutations in non-small cell lung cancer: an audit from West China Hospital.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.